Shares of Halma plc (LON:HLMA – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the eight research firms that are covering the stock, MarketBeat reports. Four investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is GBX 3,737.50.
Separately, Shore Capital Group reiterated a “hold” rating on shares of Halma in a research note on Monday, April 13th.
Read Our Latest Analysis on Halma
Halma Trading Down 0.1%
Halma Company Profile
Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad markets it operates in:
– Safety – Protecting people’s safety and the environment as populations grow, and enhancing worker safety.
– Environment – Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.
– Health – Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.
Halma employs over 9,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific.
Featured Stories
- Five stocks we like better than Halma
- The Palantir Paradox—Record Numbers and a Stock That Won’t Cooperate
- TJX Companies Fires on All Cylinders With 9% Revenue Growth
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
Receive News & Ratings for Halma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halma and related companies with MarketBeat.com's FREE daily email newsletter.
